-
272021.10NEWS
HanAll Biopharma Reports Third Quarter 2021 Results
HanAll Biopharma Reports Third Quarter 2021 Results
-
202021.10NEWS
HanAll\'s Partner HBM Completes First Dosing of Phase 2 of B..
HanAll\'s Partner HBM Completes First Dosing of Phase 2 of Batoclimab in TED in China
-
022021.09NEWS
HanAll\'s Partner HBM Announces IND Approval for Phase 2 of ..
HanAll\'s Partner HBM Announces IND Approval for Phase 2 of Batoclimab in CIDP in China
-
202021.08NEWS
HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD ..
HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD in Alloplex Biotherapeutics
-
282021.07NEWS
HanAll Biopharma Reports Second Quarter 2021 Results
HanAll Biopharma Reports Second Quarter 2021 Results
-
222021.07NEWS
HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of..
HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of HL036 in Dry Eye Disease